| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 148 | 62 | 207.392 | 271.747 | 250.949 | 106.932 |
| Total Income - EUR | - | - | - | 0 | 148 | 62 | 207.392 | 298.703 | 251.428 | 107.016 |
| Total Expenses - EUR | - | - | - | 99 | 0 | 40 | 200.475 | 264.634 | 219.170 | 96.571 |
| Gross Profit/Loss - EUR | - | - | - | -99 | 148 | 22 | 6.917 | 34.069 | 32.259 | 10.445 |
| Net Profit/Loss - EUR | - | - | - | -99 | 143 | 20 | 4.885 | 31.751 | 30.219 | 8.756 |
| Employees | - | - | - | 0 | 0 | 0 | 28 | 34 | 23 | 9 |
Check the financial reports for the company - Grikbio Team S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 51 | 197 | 216 | 37.173 | 66.432 | 45.163 | 6.496 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 5.827 | 53.279 | 45.076 | 1.644 |
| Cash | - | - | - | 51 | 197 | 216 | 31.346 | 13.153 | 87 | 4.853 |
| Shareholders Funds | - | - | - | -57 | 88 | 106 | 4.989 | 33.378 | 30.573 | 8.804 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 107 | 110 | 110 | 32.184 | 33.054 | 24.193 | 7.241 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8121 - 8121" | |||||||||
| CAEN Financial Year |
8121
|
|||||||||
Comments - Grikbio Team S.r.l.